trending Market Intelligence /marketintelligence/en/news-insights/trending/cpMgWqxz4vtIHB5Llvmvsg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sol-Gel Technologies prices $10M ordinary share offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Sol-Gel Technologies prices $10M ordinary share offering

Sol-Gel Technologies Ltd. priced an underwritten public offering of 1,250,000 ordinary shares at $8 per share.

The Israel-based dermatology company also granted underwriters a 30-day option to buy up to an additional 187,500 ordinary shares at the same price.

Gross proceeds are expected to be about $10 million. Sol-Gel plans to use net proceeds for the pre-commercialization activities for its skin creams Epsolay and Twin.

Part of the proceeds will also be used for working capital and other general corporate purposes.

Jefferies LLC is acting as sole book-running manager for the offer.

The offering is expected to close on or about Aug. 12.